| Literature DB >> 16286609 |
Barbara Fletcher, Kathy Berra, Phil Ades, Lynne T Braun, Lora E Burke, J Larry Durstine, Joan M Fair, Gerald F Fletcher, David Goff, Laura L Hayman, William R Hiatt, Nancy Houston Miller, Ronald Krauss, Penny Kris-Etherton, Neil Stone, Janet Wilterdink, Mary Winston.
Abstract
Current data and guidelines recommend treating abnormal blood lipids (ABL) to goal. This is a complex process and requires involvement from various healthcare professionals with a wide range of expertise. The model of a multidisciplinary case management approach for patients with ABL is well documented and described. This collaborative approach encompasses primary and secondary prevention across the lifespan, incorporates nutritional and exercise management as a significant component, defines the importance and indications for pharmacological therapy, and emphasizes the importance of adherence. Use of this collaborative approach for the treatment of ABL ultimately will improve cardiovascular and cerebrovascular morbidity and mortality.Entities:
Mesh：
Substances：
Year: 2005 PMID： 16286609 DOI： 10.1161/CIRCULATIONAHA.105.169180
Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690